Increased susceptibility of Atlantic salmon Salmo salar to infections with Gyrodactylus derjavini induced by dexamethasone bath treatment

• Published in: Journal of Helminthology
• Main Authors: Nielsen, C. V., Buchmann, K.
• Format: Article in Journal/Newspaper
• Language: English
• Published: 2003
• Subjects: Atlantic salmon; Salmo salar
• Online Access: https://curis.ku.dk/portal/da/publications/increased-susceptibility-of-atlantic-salmon-salmo-salar-to-infections-with-gyrodactylus-derjavini-induced-by-dexamethasone-bath-treatment(d6c8693b-ecba-41f3-be36-309de7fcb1b2).html; https://doi.org/10.1079/JOH2002159

Dexamethasone, a known immunosuppressant, was administered by bath or injection to Atlantic salmon Salmo salar (Conon stock) to study if this treatment could affect the susceptibility of fish to infections with a Danish strain of Gyrodactylus derjavini (Monogenea). Three groups of S. salar (Conon stock) were immersion treated either with 10, 60 or 240 μg dexamethasone 1 -1 water, respectively. In addition, one group (positive control) was treated intraperitoneally with 200 μg dexamethasone per fish and one negative control group was kept untreated. A single G. derjavini parasite was placed on the anal fin of each fish and the infection was subsequently monitored weekly for 6 weeks. An increase in parasite populations on the salmon was positively correlated with the amount of immunosuppressant used. Infection levels in the group immersion treated with dexamethasone (240 μg1 -1 water) and in the i.p. treated positive control group were significantly higher compared to the untreated control group.